clinical trial · NCT06285695
Clareon Toric Study (T2-T9)
Alcon Research·N/A·active not recruiting·n = 129
AphakiaCorneal AstigmatismClareon Toric IOLCataract surgery
brief summary
The purpose of this post-market study is to describe the long-term safety and performance of Clareon Toric Intraocular Lenses (IOLs).
started
Apr 10, 2024
primary completion
Jul 1, 2028
completion
Jul 1, 2028
last updated
Sep 18, 2025
detailed description
Subjects will attend up to 12 scheduled visits (one preoperative visit, up to two surgical visits, and up to 9 postoperative visits) over the course of the study (3 years follow-up). The overall study duration is expected to be approximately 4 years. This study will be conducted in Canada.
official title
Clareon Toric Single Arm Study (T2-T9)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol